HCP Practice Characteristics
HCP practice characteristics were broadly similar across regions (N=983)1
aIn the US, HCPs were defined as academic/COE if 50% or more of their practice was based in a hospital with academic affiliation and/or a specialized cancer center. In other countries, HCPs were defined as academic/COE if 50% or more of their practice was based in a COE or teaching hospital, or a cancer center if in France. HCPs were defined as community if their practice was based in less than 50% of these types of institutions.2
bCAR T-cell therapies percentages do not include respondents from UK.1
cIncludes BCMA-directed or GPRC5D-directed BsAbs.1
dBsAb percentages do not include respondents from Japan.1
BsAb, bispecific antibody; CAR, chimeric antigen receptor; COE, center of excellence; HCP, health care professional.
Click below to explore key survey insights and calls to action
References
- Ailawadhi S, Biru Y, Clavreul S, et al. Perspectives of healthcare providers and patients with relapsed/refractory multiple myeloma on treatment priorities and novel therapies. Patient Prefer Adherence.
2025;19:1089-1104. Published April 2, 2025. Taylor & Francis Ltd. Reprinted by permission of the publisher Informa UK Limited trading as Taylor & Francis Ltd, http://www.tandfonline.com - Data on file. Pfizer Inc., New York, NY.